Burning Rock Biotech Ltd reports results for the quarter ended in March - Earnings Summary

Burning Rock Biotech

31/05/2022 14:31

* Burning Rock Biotech Ltd  BNR.OQ  reported a quarterly
adjusted
loss of CNY2.50​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of CNY2.41 per share.
    * Revenue rose 27.1% to CNY135.52 million from a year ago; 
analysts expected CNY138.40 million. 
    * Burning Rock Biotech Ltd's reported EPS for the quarter
was a
loss of CNY2.50​.
    * The mean earnings estimate of analysts had fallen by
about 28.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Burning Rock Biotech Ltd shares had fallen by 74.4% this
quarter and lost 75.0% so far this year.
    * The company reported a quarterly loss of CNY261.39
million.
    * Wall Street's median 12-month price target for Burning
Rock
Biotech Ltd is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 31 at 01:30 p.m.  ​All
figures in Chinese yuan renminbi unless otherwise stated